In a 13D filing after the close on Bausch & Lomb Inc. (NYSE: BOL), SAC Capital / Steven A. Cohen disclosed a 5.5% stake (2,989,995 shares) in the company. The firm held 33,800 BOL shares at tHe quarter ended March 31, 2007.
In a boilerplate disclosure, SAC said they intend to monitor the investment and may seek discussions with management or the board in the future.
Late Thursday, Advanced Medical Optics (NYSE: EYE) announced a $75 per share offer for Bausch & Lomb, topping a $65 bid from private equity firm Warburg Pincus.
BOL 1-yr chart